The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship
Open accessAbstract
The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute collects data on cancer diagnoses, treatment, and survival for approximately 30% of the United States (US) population. To reflect advances in research and oncology practice, approaches to cancer control are evolving from simply enumerating the development of cancers by organ site in populations to including monitoring of cancer occurrence by histopathologic and molecular subtype, as defined by driver mutations and other alterations. SEER is an important population-based resource for understanding the implications of pathology diagnoses across demographic groups, geographic regions, and time and provides unique insights into the practice of oncology in the US that are not attainable from other sources. It provides incidence, survival, and mortality data for histopathologic cancer subtypes, and data by molecular subtyping are expanding. The program is developing systems to capture additional biomarker data, results from special populations, and expand biospecimen banking to enable cutting-edge cancer research and oncology practice. Pathology has always been central and critical to the effectiveness of SEER, and strengthening this relationship in this modern era of cancer diagnosis could be mutually beneficial. Achieving this goal requires close interactions between pathologists and the SEER program. This review provides a brief overview of SEER, focuses on facets relevant to pathology practice and research, and highlights the opportunities and challenges for pathologists to benefit from and enhance the value of SEER data.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Early detection, diagnosis, and treatment are crucial to the survival outcomes of esophageal cancer, and the 5-year survival rate of early-stage patients can exceed 95%.
“Early detection, diagnosis, and treatment are crucial to the survival outcomes of esophageal cancer, and the 5-year survival rate of early-stage patients can exceed 95% [6].”
From Symptom Experiences before Medical Help-Seeking and Psychosocial Responses of Patients with Esophageal Cancer: A Qualitative Study. (2023) · cites this paper as [6]
The SEER Data Analyses section says survival can reflect early detection or better treatment, which supports the general connection. It does not address esophageal cancer specifically or report a five-year survival rate exceeding 95% for early-stage patients; the Birth Cohort-Effect and Calendar-Period Effect section also cautions that earlier detection can inflate survival estimates without changing mortality. No page numbers were provided for these passages. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831 · see citing works
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334 · see citing works
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Howlader, N., Altekruse, S. F., Li, C. I., Chen, V. W., Clarke, C. A., Ries, L. A. G., & Cronin, K. A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju055 · Cited by 1,518 · see citing works
Self-citationLindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280 · see citing works
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 981 · see citing works
Albain, K. S., Unger, J. M., Crowley, J. J., Coltman, C. A., & Hershman, D. L. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp175 · Cited by 458 · see citing works
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Đačić, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J., Squire, J. A., et al. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.001 · Cited by 458 · see citing works
Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002
Criscione, V. D., & Weinstock, M. A. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.09.006 · Cited by 350 · see citing works
Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis
Adegoke, O. O., Kulasingam, S., & Virnig, B. A. (2012) · Journal of Women s Health · doi:10.1089/jwh.2011.3385 · Cited by 344 · see citing works
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Beral, V., REEVES, G. K., Bull, D., Green, J., & Collaborators, F. T. M. W. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq527 · Cited by 290 · see citing works
Identification of Novel Genetic Markers of Breast Cancer Survival
Guo, Q. J., Schmidt, M. K., Kraft, P., Canisius, S., Chen, C., Khan, S., Tyrer, J. P., Bolla, M. K., Wang, Q., Dennis, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv081 · Cited by 234 · see citing works
NCI SEER public-use data: applications and limitations in oncology research.
Yu, J. B., Gross, C. P., Wilson, L. D., & Smith, B. D. (2009) · PubMed · Cited by 234 · see citing works
Standardized synoptic cancer pathology reporting: A population‐based approach
Srigley, J. R., McGowan, T. S., MacLean, A., Raby, M., Ross, J., Krämer, S., & Sawka, C. A. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21282 · Cited by 201 · see citing works
Molecular Pathology of Pancreatic Cancer
Wood, L. D., Adsay, V. N., & Hruban, R. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4900-3_2 · Cited by 182 · see citing works
Menashe, I., Anderson, W. F., Jatoi, I., & Rosenberg, P. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp176 · Cited by 170 · see citing works
Self-citationPark, H. S.-M., Lloyd, S. A. J., Decker, R. H., Wilson, L. D., & Yu, J. B. (2012) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2012.03.007 · Cited by 156 · see citing works
Rositch, A. F., Nowak, R. G., & Gravitt, P. E. (2014) · Cancer · doi:10.1002/cncr.28548 · Cited by 152 · see citing works
Buckner, J. C., Schomberg, P. J., McGinnis, W. L., Cascino, T. L., Scheithauer, B. W., O'Fallon, J. R., Morton, R. F., Kuross, S. A., Mailliard, J. A., Hatfield, A. K., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2 · Cited by 138 · see citing works
Limitations and Biases of the Surveillance, Epidemiology, and End Results Database
Park, H. S.-M., Lloyd, S. A. J., Decker, R. H., Wilson, L. D., & Yu, J. B. (2012) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2012.03.011 · Cited by 134 · see citing works
Dinh, K. T., Mahal, B. A. V., Ziehr, D. R., Muralidhar, V., Chen, Y., Viswanathan, V. B., Nezolosky, M. D., Beard, C. J., Choueiri, T. K., Martin, N. E., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.02.015 · Cited by 126 · see citing works
The Molecular Pathology of Pancreatic Cancer
Lemoine, N. R. (1993) · Springer eBooks · doi:10.1007/978-3-642-77437-9_63 · Cited by 124 · see citing works
Field, R. W., Smith, B. J., Platz, C. E., Robinson, R. A., Neuberger, J. S., Brus, C. P., & Lynch, C. F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh189 · Cited by 109 · see citing works
Thirunavukarasu, P., Talati, C., Munjal, S., Attwood, K. M., Edge, S. B., & Francescutti, V. A. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.0871 · Cited by 103 · see citing works
Jordan, S. E., Watkins, A. J., Storey, M., Allen, S. J., Brooks, C. J., Garaiová, I., Heaven, M. L., Jones, R. H., Plummer, S. F., Russell, I. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067912 · Cited by 96 · see citing works
Contagion of Cooperation in Static and Fluid Social Networks
Jordan, J. J., Rand, D., Arbesman, S., Fowler, J., & Christakis, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066199 · Cited by 85 · see citing works
Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer
Volinia, S., Nuovo, G. J., Drusco, A., Costinean, S., Abujarour, R., Desponts, C., Garofalo, M., Baffa, R., Aeqilan, R., Maharry, K. S., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju324 · Cited by 78 · see citing works
Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., Nair, R. V., Shultz, D. B., Nair, V. S., Hoang, C. D., West, R. B., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv211 · Cited by 77 · see citing works
Dinan, M. A., Mi, X., Reed, S. D., Lyman, G. H., & Curtis, L. H. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2722 · Cited by 60 · see citing works
Chamberlain, R. S., Lau, C. S. M., & Mahendraraj, K. (2015) · Cancer Management and Research · doi:10.2147/cmar.s88561 · Cited by 45 · see citing works
SEER Cancer Registry Biospecimen Research: Yesterday and Tomorrow
Altekruse, S. F., Rosenfeld, G. E., Carrick, D. M., Pressman, E. J., Schully, S. D., Mechanic, L. E., Cronin, K. A., Hernandez, B. Y., Lynch, C. F., Cozen, W., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0490 · Cited by 45 · see citing works
Self-citationTwist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer
Song, Y. H., Shiota, M., Yokomizo, A., Uchiumi, T., Kiyoshima, K., Kuroiwa, K., Oda, Y., & Naito, S. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.11.003 · Cited by 42 · see citing works
Shuch, B. M., Hofmann, J. N., Merino, M. J., Nix, J. W., Vourganti, S., Linehan, W. M., Schwartz, K., Ruterbusch, J. J., Colt, J. S., Purdue, M. P., et al. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.08.011 · Cited by 41 · see citing works
Effect of Changing Breast Cancer Incidence Rates on the Calibration of the Gail Model
Schonfeld, S. J., Pee, D., Greenlee, R. T., Hartge, P. A., Lacey, J. V., Park, Y., Schatzkin, A. G., Visvanathan, K., & Pfeiffer, R. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2767 · Cited by 40 · see citing works
Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas
Wang, M., Ping, J., Li, Y., Holmqvist, A., Adell, G., Arbman, G., Zhang, H., Zhou, Z., & Sun, X. (2015) · Medicine · doi:10.1097/md.0000000000002350 · Cited by 40 · see citing works
Sun, M., & Trinh, Q. (2015) · British Journal of Urology · doi:10.1111/bju.13226 · Cited by 37 · see citing works
Wong, S. M., Freedman, R. A., Sagara, Y., Stamell, E. F., Desantis, S. D., Barry, W. T., & Golshan, M. A. (2015) · Cancer · doi:10.1002/cncr.29687 · Cited by 35 · see citing works
Matsuno, R. K., Sherman, M. E., Visvanathan, K., Goodman, M. T., Hernandez, B. Y., Lynch, C. F., Ioffe, O. B., Horio, D. T., Platz, C. E., Altekruse, S. F., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0157-5 · Cited by 33 · see citing works
Self-citationPopulation‐based assessment of determining predictors for quality of prostate cancer surveillance
Chamie, K., Williams, S. B., Hershman, D. L., Wright, J. D., Nguyen, P. L., & Hu, J. C. (2015) · Cancer · doi:10.1002/cncr.29574 · Cited by 24 · see citing works
Core Components of a Comprehensive Quality Assurance Program in Anatomic Pathology
Nakhleh, R. E. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181bb6bf7 · Cited by 23 · see citing works
Pathology graduate medical education (overview from 2006-2010)
Alexander, C. B. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.11.008 · Cited by 18 · see citing works
Rose, B. S., Jiang, W., & Punglia, R. S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3451-y · Cited by 16 · see citing works
Greater absolute risk for all subtypes of breast cancer in the US than Malaysia
Horne, H. N., Devi, C. R. B., Sung, H., Tang, T. S., Rosenberg, P. S., Hewitt, S. M., Sherman, M. E., Anderson, W. F., & Yang, X. R. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3243-9 · Cited by 12 · see citing works
Self-citationEffect of Screening Mammography on Cancer Incidence and Mortality
Elmore, J. G., & Etzioni, R. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.3056 · Cited by 10 · see citing works
Hall, K. N., & Kothari, R. (1999) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.1999.tb00097.x · Cited by 7 · see citing works
Categorization of cancer through genomic complexity could guide research and management strategies
Horlings, H. M., Flanagan, A. M., & Huntsman, D. D. (2015) · The Journal of Pathology · doi:10.1002/path.4542 · Cited by 5 · see citing works
Rosenberg, P. S., Menashe, I., Jatoi, I., & Anderson, W. F. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp510 · Cited by 4 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Zhou, Y., Yang, D., Yang, Q., Lv, X., Huang, W., Zhou, Z., Wang, Y., Zhang, Z., Yuan, T., Ding, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20059-6 · Cited by 672 · see citing works
Ward, E., Sherman, R., Henley, S. J., Jemal, A., Siegel, D. A., Feuer, E. J., Firth, A. U., Kohler, B., Scott, S., Ma, J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz106 · Cited by 324 · see citing works
Blackford, A. L., Canto, M. I., Klein, A. P., Hruban, R. H., & Goggins, M. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa004 · Cited by 270 · see citing works
Atkinson, E. G., Maihofer, A. X., Kanai, M., Martin, A. R., Karczewski, K. J., Santoro, M. L., Ulirsch, J. C., Kamatani, Y., Okada, Y., Finucane, H. K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00766-y · Cited by 229 · see citing works
Zhang, L.-X., Gao, J., Long, X., Zhang, P., Yang, X., Zhu, S., Pei, X., Qiu, B., Chen, S., Lü, F., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01586-w · Cited by 145 · see citing works
Che, W., Li, Y.-J., Tsang, C. K., Wang, Y., Chen, Z., Wang, X., Xu, A.-D., & Lyu, J. (2023) · Military Medical Research · doi:10.1186/s40779-023-00488-2 · Cited by 132 · see citing works
Wu, J.-I., & Wang, L. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0497-x · Cited by 128 · see citing works
Epidemiology of Signet Ring Cell Adenocarcinomas
Benesch, M. G. K., & Mathieson, A. (2020) · Cancers · doi:10.3390/cancers12061544 · Cited by 123 · see citing works
Gao, J., Li, H.-R., Jin, C., Jiang, J., & Ding, J. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02075-1 · Cited by 112 · see citing works
Montminy, E. M., Zhou, M., Maniscalco, L. S., Abualkhair, W. H., Kim, M. K., Siegel, R. L., Wu, X., Itzkowitz, S. H., & Karlitz, J. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0068 · Cited by 104 · see citing works
Codipilly, D. C., Sawas, T., Dhaliwal, L. S., Johnson, M. L., Lansing, R. L., Wang, K. K., Leggett, C. L., Katzka, D. A., & Iyer, P. G. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0944 · Cited by 98 · see citing works
Epidemiology of synchronous brain metastases
Singh, R. B., Stoltzfus, K. C., Chen, H., Louie, A. V., Lehrer, E. J., Horn, S. R., Palmer, J. D., Trifiletti, D. M., Brown, P. D., & Zaorsky, N. G. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa041 · Cited by 94 · see citing works
Shallis, R. M., Wang, R., Davidoff, A. J., Ma, X., Podoltsev, N. A., & Zeidan, A. M. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100706 · Cited by 87 · see citing works
Yu, Z., Bai, X., Zhou, R., Ruan, G., Guo, M., Han, W., Jiang, S., & Yang, H. B. (2023) · International Journal of Cancer · doi:10.1002/ijc.34740 · Cited by 84 · see citing works
Zhai, Z., Zhang, F., Zheng, Y., Zhou, L., Tian, T., Lin, S., Deng, Y., Xu, P., Hao, Q., Li, N., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2352 · Cited by 79 · see citing works
Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling
Wu, J.-I., Lin, Y., Tseng, C.-W., Chen, H.-J., & Wang, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37443-4 · Cited by 79 · see citing works
The National Cancer Database Conforms to the Standardized Framework for Registry and Data Quality
Palis, B. E., Janczewski, L. M., Browner, A. E., Cotler, J. H., Nogueira, L., Richardson, L. C., Benard, V. B., Wilson, R. J., Walker, N., McCabe, R. M., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-15393-8 · Cited by 74 · see citing works
Law, H. C.-H., Lagundžin, D., Clement, E. J., Qiao, F., Wagner, Z. S., Krieger, K. L., Costanzo-Garvey, D. L., Caffrey, T. C., Grem, J. L., DiMaio, D. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1496 · Cited by 71 · see citing works
Zhu, W., He, B., Wang, X., Du, Y., Young, K., & Jiang, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-23475-9 · Cited by 74 · see citing works
Bohn, A., Braley, A. E., de la Vega, P. R., Zevallos, J. C., & Barengo, N. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198581 · Cited by 67 · see citing works
Fan, K. M., Rimal, J., Zhang, P., & Johnson, N. W. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101673 · Cited by 65 · see citing works
Longacre, C. F., Neprash, H. T., Shippee, N. D., Tuttle, T. M., & Virnig, B. A. (2019) · The Journal of Rural Health · doi:10.1111/jrh.12413 · Cited by 63 · see citing works
Bae, H., Song, G., Lee, J., Hong, T., Chang, M., & Lim, W. (2020) · Marine Drugs · doi:10.3390/md18030152 · Cited by 61 · see citing works
Disruption of Endoplasmic Reticulum and ROS Production in Human Ovarian Cancer by Campesterol
Bae, H., Park, S., Yang, C., Song, G., & Lim, W. (2021) · Antioxidants · doi:10.3390/antiox10030379 · Cited by 61 · see citing works
Dynamic changes in marital status and survival in women with breast cancer: a population-based study
Ding, W., Ruan, G., Lin, Y.-L., Zhu, J., Tu, C., & Li, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-84996-y · Cited by 55 · see citing works
Liu, Y., Wang, D.-W., Yang, Z.-C., Ma, R., Zhong, L., Wei, S., Zhao, Z., & Li, Z. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05385-8 · Cited by 55 · see citing works
The survival of esophageal cancer by subtype in China with comparison to the United States
An, L., Zheng, R., Zeng, H., Zhang, S., Chen, R., Wang, S., Sun, K., Li, L., Wei, W., & He, J. (2022) · International Journal of Cancer · doi:10.1002/ijc.34232 · Cited by 51 · see citing works
McClelland, P. H.-T., Liu, T., & Özüner, G. (2021) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2021.11.003 · Cited by 46 · see citing works
Unified fair federated learning for digital healthcare
Zhang, F., Shuai, Z., Kuang, K., Wu, F. Q., Zhuang, Y., & Xiao, J. (2023) · Patterns · doi:10.1016/j.patter.2023.100907 · Cited by 46 · see citing works
Ghosh, S. K., Feagan, B. G., Ott, E., Gasink, C., Godwin, B. C., Marano, C. W., Ye, M., Ma, T., Loftus, E. V., Sandborn, W. J., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae013 · Cited by 46 · see citing works
Epidemiology and Survival Outcomes in Stages II and III Cutaneous Melanoma: A Systematic Review
Miller, R., Walker, S. L. M., Shui, I. M., Brandtmuller, A., Cadwell, K. K., & Scherrer, E. (2020) · Melanoma Management · doi:10.2217/mmt-2019-0022 · Cited by 46 · see citing works
Mixture Cure Models in Oncology: A Tutorial and Practical Guidance
Felizzi, F., Paracha, N., Pöhlmann, J., & Ray, J. A. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00260-z · Cited by 46 · see citing works
Epidemiology of Mucinous Adenocarcinomas
Benesch, M. G. K., & Mathieson, A. (2020) · Cancers · doi:10.3390/cancers12113193 · Cited by 45 · see citing works
Liu, W., Li, L., Bai, X., Zhang, M., Lv, W., Ma, Y., Sun, Y., Zhang, H., Jiang, Q., Yao, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202409870 · Cited by 46 · see citing works
Wang, H., Mislati, R., Ahmed, R., Vincent, P., Nwabunwanne, S. F., Gunn, J. R., Pogue, B. W., & Doyley, M. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2684 · Cited by 43 · see citing works
Nelson, D. B., Cata, J. P., Niu, J., Mitchell, K. G., Vaporciyan, A. A., Antonoff, M. B., Hofstetter, W. L., Giordano, S. H., Sepesi, B., Mehran, R. J., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001630 · Cited by 43 · see citing works
A Comparative Analysis of Deep Learning Approaches for Predicting Breast Cancer Survivability
Gupta, S., & Gupta, M. K. (2021) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-021-09679-3 · Cited by 41 · see citing works
Snow, A. E., Ring, A., Struycken, L., Mack, W. J., Koç, M., & Lang, J. E. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101857 · Cited by 40 · see citing works
Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992–2019
Phung, M. T., Pearce, C. L., Meza, R., & Jeon, J. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0410 · Cited by 39 · see citing works
Movahedpour, A., Ahmadi, N., Ghasemi, Y., Savardashtaki, A., & Shabaninejad, Z. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29053 · Cited by 39 · see citing works
Corona, E., Yang, L., Esrailian, E., Ghassemi, K. A., Conklin, J. L., & May, F. P. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01443-z · Cited by 38 · see citing works
Russo, D., Mariani, P., Caponio, V. C. A., Russo, L. L., Fiorillo, L., Zhurakivska, K., Muzio, L. L., Laino, L., & Troiano, G. (2021) · Cancers · doi:10.3390/cancers13225755 · Cited by 37 · see citing works
Nomogram for predicting the survival of patients with malignant melanoma: A population analysis
Yang, J., Pan, Z., Zhou, Q., Liu, Q., Zhao, F., Feng, X., & Lyu, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10720 · Cited by 36 · see citing works
Eberth, J. M., Zahnd, W. E., Adams, S. A., Friedman, D. B., Wheeler, S. B., & Hébert, J. R. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105849 · Cited by 35 · see citing works
Yao, C., Ng, E., & Wang, S. X. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.113982 · Cited by 35 · see citing works
The role of socioeconomic disparity in colorectal cancer stage at presentation
Patel, A. D., Gantz, O. B., Zagadailov, P., & Merchant, A. M. (2019) · Updates in Surgery · doi:10.1007/s13304-019-00632-5 · Cited by 34 · see citing works
Cao, L., Li, Z., Wang, M., Zhang, T., Bao, B., & Liu, Y. (2019) · PeerJ · doi:10.7717/peerj.6539 · Cited by 34 · see citing works
Epithelioid sarcoma: half a century later
Elsamna, S. T., Amer, K. M., Elkattawy, O., & Beebe, K. S. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1659514 · Cited by 34 · see citing works
Secondary databases in gynecologic cancer research
Hicks-Courant, K., Ko, E. M., Matsuo, K., Melamed, A., Nasioudis, D., Rauh‐Hain, J. A., Uppal, S., Wright, J. D., & Ramirez, P. T. (2024) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2024-005677 · Cited by 33 · see citing works
Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis
Longacre, C. F., Neprash, H. T., Shippee, N. D., Tuttle, T. M., & Virnig, B. A. (2021) · Women s Health Reports · doi:10.1089/whr.2020.0094 · Cited by 33 · see citing works
A population-based study on incidence trends of myeloma in the United States over 2000–2020
Mousavi, S. E., Ilaghi, M., Aslani, A., Yekta, Z., & Nejadghaderi, S. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-47906-y · Cited by 32 · see citing works
Amer, H., Kartikasari, A. E. R., & Plebanski, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121335 · Cited by 34 · see citing works
Dong, B., Zhang, H., Duan, Y., Yao, S., Chen, Y., & Zhang, C. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05203-w · Cited by 32 · see citing works
Xiang, M. H., English, D. P.-G., & Kidd, E. A. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.007 · Cited by 31 · see citing works
Lin, Y., Wu, J.-I., Tseng, C.-W., Chen, H.-J., & Wang, L. (2018) · Oncogene · doi:10.1038/s41388-018-0471-1 · Cited by 30 · see citing works
Diao, J., Ma, L., Sun, M., Wu, C., Wang, L., Liu, Y., & Yang, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2470 · Cited by 29 · see citing works
Competing‐risks model for predicting the prognosis of penile cancer based on the SEER database
Yang, J., Pan, Z., He, Y., Zhao, F., Feng, X., Liu, Q., & Lyu, J. (2019) · Cancer Medicine · doi:10.1002/cam4.2649 · Cited by 29 · see citing works
U-Net and SegNet performances on lesion segmentation of breast ultrasonography images
Vianna, P., Farias, R., & Pereira, W. C. D. A. (2021) · Research on Biomedical Engineering · doi:10.1007/s42600-021-00137-4 · Cited by 29 · see citing works
Sutton, T. L., Beneville, B., Johnson, A. J., Mayo, S. C., Gilbert, E. W., Lopez, C. D., Grossberg, A. J., Rocha, F. G., & Sheppard, B. C. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.6709 · Cited by 28 · see citing works
Mezencev, R., & Chernoff, Y. O. (2020) · Cancers · doi:10.3390/cancers12040796 · Cited by 27 · see citing works
Huang, R. J., Sharp, N., Talamoa, R., Ji, H. P., Hwang, J. H., & Palaniappan, L. P. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1482 · Cited by 27 · see citing works
Deibel, A., Deng, L., Cheng, C., Schlander, M., Ran, T., Lang, B. M., Krupka, N., Beerenwinkel, N., Rogler, G., Wiest, R., et al. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2021.02.013 · Cited by 26 · see citing works
Defining rurality: an evaluation of rural definitions and the impact on survival estimates
Franks, J. A., Davis, E., Bhatia, S., & Kenzik, K. M. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad031 · Cited by 26 · see citing works
Li, Z., Lin, Y., Cheng, B., Zhang, Q., & Cai, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.651975 · Cited by 25 · see citing works
Lim, D. W., Giannakeas, V., & Narod, S. A. (2020) · JCO Global Oncology · doi:10.1200/go.20.00316 · Cited by 24 · see citing works
The role of sex genotype in paediatric CNS tumour incidence and survival
Soon, W. C., Goacher, E., Solanki, S. P., Hayes, J. L., Kapetanstrataki, M., Picton, S. V., Chumas, P., & Mathew, R. K. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05165-0 · Cited by 24 · see citing works
Li, W., Hong, T., Liu, W., Dong, S., Wang, H., Tang, Z., Li, W., Wang, B., Hu, Z., Liu, Q., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.807382 · Cited by 24 · see citing works
Williams, C. D., Alpert, N., Redding, T. S., Bullard, A. J., Flores, R. M., Kelley, M. J., & Taioli, E. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0245 · Cited by 24 · see citing works
Association between socioeconomic status and survival in patients with hepatocellular carcinoma
Zheng, Y., Zhang, X., Lu, J., Liu, S., & Qian, Y. (2021) · Cancer Medicine · doi:10.1002/cam4.4223 · Cited by 23 · see citing works
Head and Neck Cancer Incidence in the United States Before and During the COVID-19 Pandemic
Semprini, J., Pagedar, N. A., Boakye, E. A., & Osazuwa‐Peters, N. (2024) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2023.4322 · Cited by 23 · see citing works
A SEER-based nomogram accurately predicts prognosis in Ewing’s sarcoma
Zhan, H., Mo, F., Zhu, M., Xu, X., Zhang, B., Liu, H., & Dai, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-02134-0 · Cited by 22 · see citing works
Should Endometrial Cancer Treatment Be Centralized?
Mandato, V. D., Palicelli, A., Torricelli, F., Mastrofilippo, V., Leone, C., Dicarlo, V., Tafuni, A., Santandrea, G., Annunziata, G., Generali, M., et al. (2022) · Biology · doi:10.3390/biology11050768 · Cited by 22 · see citing works
Precision information extraction for rare disease epidemiology at scale
Kariampuzha, W. Z., Alyea, G., Qu, S., Sanjak, J. S., Mathé, E. A., Sid, E., Chatelaine, H., Yadaw, A. S., Xu, Y., & Zhu, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04011-y · Cited by 22 · see citing works
Persistence of data-driven knowledge to predict breast cancer survival
Kleinlein, R., & Riaño, D. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.06.018 · Cited by 22 · see citing works
Xie, T., Qiu, B.-M., Luo, J., Diao, Y., Hu, L., Liu, X., & Shen, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-73389-6 · Cited by 21 · see citing works
Gang, J., Yan, Q., Song, X., Zheng, L., & Zhao, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6213 · Cited by 21 · see citing works
Use of the Decipher genomic classifier among men with prostate cancer in the United States
Zaorsky, N. G., Proudfoot, J. A., Jia, A. Y., Zuhour, R. J., Vince, R., Liu, Y., Zhao, X., Hu, J. C., Schussler, N. C., Stevens, J. L., et al. (2023) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkad052 · Cited by 21 · see citing works
Low-rank and sparse representation based learning for cancer survivability prediction
Yang, J., Ma, J., Win, K. T., Gao, J., & Yang, Z. (2021) · Information Sciences · doi:10.1016/j.ins.2021.10.013 · Cited by 20 · see citing works
Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors
Yavvari, S., Makena, Y., Sukhavasi, S., & Makena, M. R. (2019) · Children · doi:10.3390/children6120130 · Cited by 20 · see citing works
Denyer, S., Bhimani, A. D., Patil, S. N., Mudreac, A., Behbahani, M., & Mehta, A. I. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03088-7 · Cited by 20 · see citing works
Li, F., Yang, Y., Du, J., Yu, Y., & Diao, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74720-7 · Cited by 21 · see citing works
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis
Huang, Y., Cao, D., Zhang, M., Yang, Y., Niu, G., Tang, L., Shen, Z., Zhang, Z., Bai, Y., Min, D., et al. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00949-3 · Cited by 20 · see citing works
Enhanced ovarian cancer survival prediction using temporal analysis and graph neural networks
Ghantasala, G. S. P., Dilip, K., Vidyullatha, P., Allabun, S. M., Alqahtani, M. S., Othman, M., Abbas, M. A. E., & Soufiene, B. O. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02665-2 · Cited by 19 · see citing works
Salazar, T., Araújo, H. J., Cano, A., & Abreu, P. H. (2026) · Artificial Intelligence Review · doi:10.1007/s10462-025-11475-5 · Cited by 26 · see citing works
Wang, S., Ma, K., Wang, Q., Sun, F., Shi, Y., Zhan, C., & Jiang, W. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.10.034 · Cited by 19 · see citing works
Chai, X., Sun, M., Jia, H., Wang, M., Cao, L., Li, Z., & Wang, D.-W. (2019) · PeerJ · doi:10.7717/peerj.7837 · Cited by 19 · see citing works
Dietary Factors and Early-Onset Colorectal Cancer in the United States—an Ecologic Analysis
Chen, J., Zhang, I. L., Terry, M. B., & Yang, W. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0442 · Cited by 19 · see citing works
Yang, J., He, G., Chen, S., Pan, Z., Zhang, J., Li, Y., & Lyu, J. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.03.022 · Cited by 19 · see citing works
Aheto, J. M. K., Utuama, O. A., & Dagne, G. A. (2021) · BMC Cancer · doi:10.1186/s12885-021-08254-0 · Cited by 19 · see citing works
Kamalapathy, P. N., Ramkumar, D. B., Karhade, A. V., Kelly, S., Raskin, K. A., Schwab, J. H., & Lozano‐Calderón, S. A. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26398 · Cited by 19 · see citing works
Xia, Y., Guan, X., Zhu, W., Wang, Y., Shi, Z., & He, P. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01812-x · Cited by 19 · see citing works
Prognostic value of lymphatic vessel density in oral squamous cell carcinoma
Chen, J., Zhang, F., Hua, M., Song, X., Liu, S., & Dong, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118746 · Cited by 18 · see citing works
Wang, Z., Liu, J., Han, J., Yang, Z., & Wang, Q. (2022) · European journal of medical research · doi:10.1186/s40001-022-00810-z · Cited by 18 · see citing works
Xu, Q., & Lü, X. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-1238 · Cited by 18 · see citing works
Wu, M., Yang, X., Liu, Y., Han, F., Li, X., Wang, J., Guo, D., Tang, X., Lü, L., & Liu, C. (2024) · BMC Public Health · doi:10.1186/s12889-024-18221-6 · Cited by 18 · see citing works
Using the “Hidden” genome to improve classification of cancer types
Chakraborty, S., Begg, C. B., & Shen, R. (2020) · Biometrics · doi:10.1111/biom.13367 · Cited by 17 · see citing works
Cheng, R., Kong, X., Wang, X., Fang, Y., & Wang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01583 · Cited by 18 · see citing works
Grothen, A., Tennant, B., Wang, C., Torres, A. D., Sheppard, B. B., Abastillas, G., Matatova, M., Warner, J. L., & Rivera, D. R. R. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00101 · Cited by 17 · see citing works
Fwelo, P., Yusuf, Z. I., Adjei, A., Huynh, G., & Du, X. L. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06653-w · Cited by 17 · see citing works
Pilleron, S., Withrow, D. R., Nicholson, B. D., & Morris, E. J. A. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102363 · Cited by 17 · see citing works
- Authors
- Duggan, M. A., Anderson, W. F., Altekruse, S., Penberthy, L., & Sherman, M. E.
- Affiliations
- University of Calgary (CA)
- Division of Cancer Epidemiology and Genetics (US)
- Cancer Control and Populations Sciences
- National Cancer Institute (US)
- Corresponding author
- Duggan, Máire A.
- Venue
- American Journal of Surgical Pathology
- Published
- 2016-12
- Volume
- 40
- Issue
- 12
- Pages
- e94-e102
- ISSN
- 0147-5185 (ISSN-L)
- PMC
- PMC5106320
- OpenAlex
- W2530755795
- Cited by
- 472
- References
- 46
- Citations by year
- 2026: 28 · 2025: 49 · 2024: 72 · 2023: 60 · 2022: 73 · 2021: 62 · 2020: 78 · 2019: 42 · 2018: 6 · 2017: 1 · 2015: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 CA999999)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
- Keywords
- cancer pathology, histological subtypes, molecular subtypes, driver mutations, cancer incidence, cancer survival, cancer mortality, biomarker data, cancer control
- MeSH terms
- Humans, Medical Oncology, Neoplasms, Pathology, Clinical, Biomarkers, Tumor, United States, SEER Program, Interdisciplinary Communication, Pathology, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
